•  
  •  
  •  
  •  

2026-08-04 21:53:30

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Deepening Our Presence in Punjab - Strengthening the Tricity Cluster
  • Mini Diamonds India Reports Strong Q1 FY27 Performance: Consolidated Net Profit Up 49.8% YoY to ₹2.67 Crore; Revenue Nearly Doubles to ₹196.53 Crore
  • Kinetic Engineering Reports Q1 FY27 Results: Net Loss at ₹12.96 Crore Amid Higher Material Costs and Inventory Movements
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • One Mobikwik Systems Turns Profitable in Q1 FY27: Reports Net Profit of ₹7.62 Crore; EBITDA Reaches ₹15.78 Crore

Keywords Selected:  InjectableFacility

Stock Report

  • Zydus Lifesciences Ltd receives EIR from the USFDA for its injectable facility with VAI classification
  • Alembic Pharmaceuticals Ltd receives 2 observations for Karakhadi Injectable Facility
  • Zydus receives EIR for the injectable facility located at Jarod
  • Closure of USFDA inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Lupin receives 6 observations from USFDA for Nagpur Injectable facility
  • Lupin receives EIR from US FDA for its Injectable Facility in Nagpur
  • Eugia Steriles Pvt Ltd receives 1st production approval from USFDA from new injectable facility
  • Lupin announces closure of US FDA Inspection at its Injectable Facility with Zero 483 Observations
  • Eugia Steriles Pvt Ltd gets 3 observations from USFDA for Injectable Facility
  • Windlas Biotech Limited commissions its State-of-the-Art Injectable facility
  • Eugia US Manufacturing LLC gets 10 observations from USFDA for East Windsor facility
  • Lupin Receives EIR from US FDA for its Injectable Facility in Nagpur
  • Alembic Pharmaceuticals Ltd receives EIR from USFDA for Injectable Facility at Karkhadi
  • Lupin receives approval from US FDA for Glycopyrrolate Injection, USP
  • USFDA inspection at Alembic Pharmaceuticals Injectable Facility (F-3) at Karkhadi
  • Zydus Lifesciences Ltd gets 3 observations from USFDA for Injectable Facility

Latest Post

  • Deepening Our Presence in Punjab - Strengthening the Tricity Cluster
  • Mini Diamonds India Reports Strong Q1 FY27 Performance: Consolidated Net Profit Up 49.8% YoY to ₹2.67 Crore; Revenue Nearly Doubles to ₹196.53 Crore
  • Kinetic Engineering Reports Q1 FY27 Results: Net Loss at ₹12.96 Crore Amid Higher Material Costs and Inventory Movements
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • One Mobikwik Systems Turns Profitable in Q1 FY27: Reports Net Profit of ₹7.62 Crore; EBITDA Reaches ₹15.78 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025